Abroug S - Search Results

1

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.

Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, Ben Hmida M, De S, Hunley TE, Jarraya F, Fraga G, Banos A, Lindner E, Dehmel B, Schalk G. Ariceta G, et al. Among authors: abroug s. Pediatr Nephrol. 2023 Feb;38(2):403-415. doi: 10.1007/s00467-022-05591-5. Epub 2022 May 12. Pediatr Nephrol. 2023. PMID: 35552824 Free PMC article. Clinical Trial.

2

Novel mutations in steroid-resistant nephrotic syndrome diagnosed in Tunisian children.

Mbarek IB, Abroug S, Omezzine A, Pawtowski A, Gubler MC, Bouslama A, Harbi A, Antignac C. Mbarek IB, et al. Among authors: abroug s. Pediatr Nephrol. 2011 Feb;26(2):241-9. doi: 10.1007/s00467-010-1694-8. Epub 2010 Dec 2. Pediatr Nephrol. 2011. PMID: 21125408

3

Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.

Benhaj Mbarek I, Abroug S, Omezzine A, Zellama D, Achour A, Harbi A, Bouslama A. Benhaj Mbarek I, et al. Among authors: abroug s. BMC Nephrol. 2011 May 25;12:25. doi: 10.1186/1471-2369-12-25. BMC Nephrol. 2011. PMID: 21612638 Free PMC article.

4

Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation.

Mbarek IB, Mdimeg S, Moussa A, Zellama D, Kaarout H, Abdelmoula J, Achour A, Abroug S, Omezzine A, Bouslama A. Mbarek IB, et al. Among authors: abroug s. BMC Nephrol. 2017 Jun 15;18(1):195. doi: 10.1186/s12882-017-0612-8. BMC Nephrol. 2017. PMID: 28619084 Free PMC article.

5

HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.

M'dimegh S, Aquaviva-Bourdain C, Omezzine A, Souche G, M'barek I, Abidi K, Gargah T, Abroug S, Bouslama A. M'dimegh S, et al. Among authors: abroug s. J Clin Lab Anal. 2017 May;31(3):e22053. doi: 10.1002/jcla.22053. Epub 2016 Aug 26. J Clin Lab Anal. 2017. PMID: 27561601 Free PMC article.

6

[Primary hyperoxaluria in children in central Tunisia].

Chemli J, Abdennabi H, Zorgati M, Abdelhak S, Nabli N, Abroug S, Sfar MT, Ben Dhia N, Amri F, Harbi A. Chemli J, et al. Among authors: abroug s. Tunis Med. 2007 Jun;85(6):513-8. Tunis Med. 2007. PMID: 17644908 French.

7

Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.

Ouali S, Bougmiza I, Abroug S, Omezzine A, Ben Salem H, Neffeti E, Remedi F, Bouslema A, Harabi A, Boughzela E. Ouali S, et al. Among authors: abroug s. Pediatr Cardiol. 2011 Jun;32(5):568-77. doi: 10.1007/s00246-011-9909-8. Epub 2011 Feb 20. Pediatr Cardiol. 2011. PMID: 21336977

8

[Henoch-Schonlein purpura and renal tuberculosis].

Chemli J, Abroug S, Harbi A. Chemli J, et al. Among authors: abroug s. Presse Med. 2004 Apr 10;33(7):456-7. doi: 10.1016/s0755-4982(04)98630-7. Presse Med. 2004. PMID: 15105765 French.

9

A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis.

Skouri H, Gandouz R, Abroug S, Kraiem I, Euch H, Gargouri J, Harbi A. Skouri H, et al. Among authors: abroug s. Am J Hematol. 2006 May;81(5):328-34. doi: 10.1002/ajh.20614. Am J Hematol. 2006. PMID: 16628723 Free article.

10

[Lupus nephritis in childhood: clinical and evolutive study of 14 cases].

Chemli J, Krid S, Boussetta S, Abroug S, Ben Dhia N, Ghedira I, Sfar MT, Essoussi AS, Harbi A. Chemli J, et al. Among authors: abroug s. Tunis Med. 2007 Aug;85(8):644-50. Tunis Med. 2007. PMID: 18254284 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page